Your browser doesn't support javascript.
loading
Corrigendum to 'TAZ is indispensable for c-MYC-induced hepatocarcinogenesis' [J Hepatol (2022) 123-134].
Wang, Haichuan; Zhang, Shanshan; Zhang, Yi; Jia, Jiaoyuan; Wang, Jingxiao; Liu, Xianqiong; Zhang, Jie; Song, Xinhua; Ribback, Silvia; Cigliano, Antonio; Evert, Matthias; Liang, Bingyong; Wu, Hong; Calvisi, Diego F; Zeng, Yong; Chen, Xin.
Afiliação
  • Wang H; Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of C
  • Zhang S; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.
  • Zhang Y; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.
  • Jia J; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA; Department of Oncology and Hematology, the Second Hospital, Jilin University, Changchun, China.
  • Wang J; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA; School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • Liu X; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA; School of Pharmacy, Hubei University of Chinese Medicine Wuhan, Hubei, China.
  • Zhang J; Department of Thoracic Oncology II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
  • Song X; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA.
  • Ribback S; Institute of Pathology, University of Greifswald, Greifswald, Germany.
  • Cigliano A; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Evert M; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Liang B; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA; Hepatic Surgery Center, Department of Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Wu H; Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Calvisi DF; Institute of Pathology, University of Regensburg, Regensburg, Germany. Electronic address: diego.calvisi@klinik.uni-regensburg.de.
  • Zeng Y; Liver Transplantation Division, Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: zengyong@medmail.com.cn.
  • Chen X; Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA. Electronic address: xin.chen@ucsf.edu.
J Hepatol ; 76(3): 755-756, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34965902
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article